Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03953859 · ClinicalTrials.gov registry record
Embryo DNA Repair Capacity Project
A clinical trial of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT03953859: Completed study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.
NCT03953859 is a study of Infertility that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 6 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03953859, a study of Infertility, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The mail aim of the present study is to use molecular methods to analyze the ability of human preimplantation embryos to repair their DNA
Primary Outcome
targeted deep sequencing to identify the presence of the double strand break in the DNA and subsequent repair ability of the embryo
Conditions Studied
Interventions
- GENETIC double strand break
Study Locations (1)
New Jersey
- Reproductive Medicine Assoicates of New Jersey - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2021-12-09 |
What the finished NCT03953859 record still lists
NCT03953859 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which double strand break is the first listed.
NCT03953859 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03953859 about?
NCT03953859 is a clinical study titled "Embryo DNA Repair Capacity Project". The mail aim of the present study is to use molecular methods to analyze the ability of human preimplantation embryos to repair their DNA
What is the current status of trial NCT03953859?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-04-04. Estimated completion is 2021-12-09.
What conditions does trial NCT03953859 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT03953859?
The interventions under investigation include: double strand break (GENETIC).
Who is sponsoring clinical trial NCT03953859?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03953859 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03953859's enrollment target sits among peer trials
6 74th of 74 higher than 1 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI